These days, many devices are programmed through apps on patients’ phones. But the FDA warns that certain phone settings, such ...

US FDA alerts patients of potential to miss critical safety alerts due to phone settings when using smartphone-compatible diabetes devices: Maryland Friday, February 7, 2025, 09:0 ...

The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...

Genetic engineering deployed to insert gene for human insulin into a bacterium, thus harnessing the substance for widespread ...

Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...

Health care providers are urged to inform patients to periodically check their smartphone settings and to confirm that they are able to receive alerts.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Unlike short-lived fixes that merely accelerate metabolism for temporary effect, Lipozem takes a root-cause approach, ...

In case 1, a diabetic patient given a single course of chromic chloride appeared to have a probable response to the drug. Within the first day of chromic chloride administration, insulin ...